WO1999038594A1 - Procede de separation de melanges de substances au moyen de polysaccharides - Google Patents
Procede de separation de melanges de substances au moyen de polysaccharides Download PDFInfo
- Publication number
- WO1999038594A1 WO1999038594A1 PCT/EP1999/000473 EP9900473W WO9938594A1 WO 1999038594 A1 WO1999038594 A1 WO 1999038594A1 EP 9900473 W EP9900473 W EP 9900473W WO 9938594 A1 WO9938594 A1 WO 9938594A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- separation
- polysaccharides
- chromatography
- microparticles
- poly
- Prior art date
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 45
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 45
- 239000000126 substance Substances 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 150000004676 glycans Chemical class 0.000 title claims abstract 3
- 238000000926 separation method Methods 0.000 title claims description 45
- 238000000034 method Methods 0.000 claims abstract description 46
- 239000011859 microparticle Substances 0.000 claims abstract description 36
- 230000008569 process Effects 0.000 claims description 27
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 11
- 238000005227 gel permeation chromatography Methods 0.000 claims description 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 6
- 238000013375 chromatographic separation Methods 0.000 claims description 6
- 238000004809 thin layer chromatography Methods 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 abstract description 19
- 150000004804 polysaccharides Chemical class 0.000 description 41
- 239000000463 material Substances 0.000 description 35
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 30
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 24
- 239000002245 particle Substances 0.000 description 21
- 239000002904 solvent Substances 0.000 description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 13
- 230000008859 change Effects 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- BHNHHSOHWZKFOX-UHFFFAOYSA-N 2-methyl-1H-indole Chemical compound C1=CC=C2NC(C)=CC2=C1 BHNHHSOHWZKFOX-UHFFFAOYSA-N 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 230000005526 G1 to G0 transition Effects 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 9
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 9
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- -1 polysiloxane Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 238000004817 gas chromatography Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- GUFMBISUSZUUCB-UHFFFAOYSA-N 1,3,5-tritert-butylbenzene Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1 GUFMBISUSZUUCB-UHFFFAOYSA-N 0.000 description 4
- 108010033764 Amylosucrase Proteins 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 229950011260 betanaphthol Drugs 0.000 description 4
- 230000002210 biocatalytic effect Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 229940097362 cyclodextrins Drugs 0.000 description 4
- 150000002016 disaccharides Chemical class 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 238000007385 chemical modification Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920001592 potato starch Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- AXRKCRWZRKETCK-UHFFFAOYSA-N 1-naphthalen-2-ylethanol Chemical compound C1=CC=CC2=CC(C(O)C)=CC=C21 AXRKCRWZRKETCK-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 238000012435 analytical chromatography Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000003822 preparative gas chromatography Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010046163 Glycogen Phosphorylase Proteins 0.000 description 1
- 108010001483 Glycogen Synthase Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108010039811 Starch synthase Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000003983 inhalation anesthetic agent Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3833—Chiral chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/285—Porous sorbents based on polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/29—Chiral phases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
- C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/68—Purification; separation; Use of additives, e.g. for stabilisation
- C07C37/70—Purification; separation; Use of additives, e.g. for stabilisation by physical treatment
- C07C37/82—Purification; separation; Use of additives, e.g. for stabilisation by physical treatment by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Definitions
- the invention relates to a method for separating mixtures of substances, in particular enantiomers, using spherical microparticles made of chemically and physically unmodified, water-insoluble, linear polysaccharides as the separating material.
- Chromatography is an effective method for the complete separation of components of a mixture, in particular for the separation of mixtures of similar compounds, e.g. of stereoisomers. Due to the increasing interest in pure enantiomers for pharmaceutically and biochemically active substances and crop protection agents, the chromatographic separation of enantiomeric compounds is of particular interest. For the purification of these compounds, continuously improved processes are being developed and better separating materials are sought, in particular based on the polysaccharides cellulose and starch, two easily accessible and inexpensive polymers with chiral atoms.
- the article Chromatographie 65, LaborPraxis, 730-738 (1990) describes the use of microcrystalline tribenzoyl cellulose with grain sizes of 10 to 20 ⁇ m in comparison to triacetyl cellulose as a sorbent for the enantiomer separation in chromatography. Both substances can be used for analytical and preparative separations. They are accessible through the derivatization of cellulose. Unmodified polymers are not used. The introduction of smaller grain sizes down to 5 ⁇ m in order to avoid dead volumes and a compression of the column that occurs during operation is described as desirable.
- WO 95/05879 also deals with the separation of enantiomers by liquid chromatography. Particular attention is paid here to the mobile phase to improve the separation performance. As a stationary phase 2
- Carbamate derivatives of cellulose and amylose and ester derivatives of cellulose are used.
- DE-A-43 17 139 describes a special process for the enantiomer separation of inhalation anesthetics by means of preparative gas chromatography.
- Cyclodextrins in polysiloxane solution on a porous carrier material (Chromosorb) derivatized with ester groups are used as the stationary phase.
- the cyclodextrins have to be chemically modified, dissolved in polysiloxane and fixed on a suitable carrier material.
- polymeric siloxanes containing cyclodextrin derivatives are used as chiral stationary phase in analytical and preparative gas chromatography (GC), chromatoraphy (LC). These peralkyl cyclodextrins are chemically bound to the polysiloxanes. The material used is thus obtained by chemical modification of the cyclodextrins and subsequent chemical fixation to polysiloxanes.
- a vinyl derivative of a polysaccharide e.g. cellulose
- a porous support e.g. silica gel
- a second variant is the copolymerization of a porous carrier (e.g. modified silica gel) containing vinyl groups with a vinyl derivative of a polysaccharide.
- a porous carrier e.g. modified silica gel
- chemical modifications are necessary in order to obtain suitable separating material.
- EP-B-0 157 365 describes stationary phases for enantiomer and isomer separation and for gel permeation chromatography based on polysaccharide carbamate derivatives.
- Cellulose, amylose, chitosan, xylan, dextran and inulin are suitable as polysaccharides.
- the powder produced can have a particle diameter of 1 ⁇ m to 300 ⁇ m directly or according to physical 3 or chemical fixation can be used on a porous support. A chemical modification is therefore necessary in order to obtain suitable separating material.
- DE-C 26 55 292 and DE-C 25 55 361 use porous gels from dextran derivatives as separation media in electrophoretic separation materials.
- dextran derivatives containing vinyl groups In order to achieve insolubility, dextran derivatives containing vinyl groups must be crosslinked by radical polymerization.
- Chemical and / or physical modifications are to be understood in particular as derivatizations through the introduction of special groups, covalent fixations on a carrier material and subsequent chemical and / or physical crosslinking.
- the object of the invention is therefore to simplify and reduce the cost of the chromatography process by circumventing chemical and physical modifications to the separation material used.
- separation material spherical microparticles made of chemically and physically unmodified, water-insoluble, linear polysaccharides (hereinafter called separation material according to the invention) as separation material.
- Spherical microparticles are to be understood as meaning microparticles which are approximately spherical in shape.
- the 4 Define the radius of the sphere in all spatial directions, for the spherical microparticles the axis lengths can deviate from 1% to 40%.
- the surface of the spherical microparticles can be compared macroscopically with that of a raspberry, the depth of the “indentations” or “incisions” being a maximum of 20% of the average diameter of the spherical microparticles.
- Figures 1 to 4 show scanning electron microscope (SEM) images (Camscan S-4) of the spherical microparticles used.
- Linear polysaccharides according to the present invention can be polyglucans or other linear polysaccharides such as pullulans, pectins, mannans or polyfructans.
- poly- (1,4- ⁇ -D-glucan) is particularly preferred.
- the separating material according to the invention can be used for the chromatographic separation of substance mixtures, particularly preferably stereoisomers, very particularly preferably enantiomers. Therefore, the use of the separating material according to the invention in preparative and analytical chromatography such as gas chromatography, preparative and analytical thin layer chromatography and in particular high performance liquid chromatography (HPLC) is of particular interest. Furthermore, the use of the separating material according to the invention in gel permeation chromatography (GPC) 5 of interest in the separation of polymers of different molecular weights.
- GPC gel permeation chromatography
- One application that also falls within the scope of the invention is the separation of substances from solutions, emulsions or suspensions through specific or non-specific interactions with low molecular weight or polymeric compounds. However, ionic compounds, in particular metal cations, are also of interest for use. Special effects can be achieved in particular due to the structural similarity to polysaccharides in the separation of monosaccharides, disaccharides and oligos
- the invention also relates to the treatment of water, in particular waste water, the analysis of biological material, in particular blood and sera, or for example the separation or separation of genetic material (nucleic acids) or other biogenic compounds (e.g. oligonucleotides, peptides, proteins).
- genetic material nucleic acids
- biogenic compounds e.g. oligonucleotides, peptides, proteins
- Chromatography in the sense of the invention is understood to mean physical separation processes in which the separation of substances takes place by distribution and / or adsorption between a stationary and a mobile phase.
- the separating material according to the invention preferably poly (1,4-alpha-D-glucan) is used as the stationary phase and combined with a liquid and / or gaseous mobile phase.
- HPLC high-LC, GPC, GC, DC and further or any specifications of chromatographic methods or methods similar to chromatography. In principle, any chromatographic method of the invention is accessible.
- HPLC High Performance (or) High Pressure Liquid Chromatography
- HPLC works with very fine material (3-10 ⁇ m), since the separation performance of a column increases with decreasing grain size of the stationary phase. The fine particle size of the separating materials requires high pressures (up to 400 bar).
- GPC Gel permeation chromatography
- Exclusion chromatography which can also be operated as HPLC, the stationary phase consists of beads with a heteroporous swollen network, the pore size distribution of which varies over several orders of magnitude, so that fractionation takes place according to molecular size, which allows the molecular size distribution of polymers to be determined quickly.
- Gas chromatography is used to separate mixtures of substances that are in gaseous form or that can be vaporized without decomposition, with a gas serving as the mobile phase.
- Gas chromatographic analysis begins with the application of a gas, an evaporable liquid or an evaporable solid to the thermostatted separation column. With the help of the carrier gas (He, N 2 or H 2 ) the substances are transported through the column, where the chromatographic separation takes place.
- He, N 2 or H 2 carrier gas
- Thin layer chromatography is a chromatographic process with a multi-stage distribution process, the stationary phase (the separating material is called sorbent here) being a thin layer on a suitable support, for example glass, polyester or aluminum. This layer separates by elution with the eluent (mobile phase).
- the invention therefore relates to the separating material according to the invention as such, containing spherical microparticles of chemically and physically unmodified, water-insoluble, linear polysaccharides and, if appropriate, further auxiliaries, additives and carriers.
- Linear polysaccharides are polysaccharides which are built up from monosaccharides, disaccharides or other monomeric units in such a way that the monosaccharides, disaccharides or other monomeric units are always linked to one another in the same way.
- Each basic unit or building block defined in this way has exactly two links, one each to a different monomer. The two basic units, which form the beginning and the end of the polysaccharide, are excluded from this. These basic units have only one link to another monomer. With three links (covalent bonds) one speaks of a branch. Branches do not occur or only to a minor extent, so that they are not accessible to the conventional analytical methods with very small branch fractions.
- Examples of preferred water-insoluble linear polysaccharides are linear poly-D-glucans, the type of linkage being immaterial as long as there is linearity in the sense of the invention.
- Examples are poly (1,4-alpha-D-glucan) and poly (1,3-beta-D-glucan), with poly (1,4-alpha-D-glucan) being particularly preferred.
- branching If the basic unit has three or more links, this is referred to as branching.
- the linear water-insoluble polysaccharides have a degree of branching of less than 8%, i.e. they have less than 8 branches per 100 basic units.
- the degree of branching is preferably less than 4% and in particular a maximum of 1.5%.
- the degree of branching in the 6-position is less than 4%, preferably a maximum of 2% and in particular a maximum of 0.5% and the degree of branching in the 8 other positions not involved in the linear linkage, for example the 2- or 3-position in the case of the preferred poly (1,4-alpha-D-glucan), is preferably in each case a maximum of 2% and in particular a maximum of 1%.
- Polysaccharides in particular poly-alpha-D-glucans, are particularly preferred which have no branches or whose degree of branching is so minimal that it can no longer be detected using conventional methods.
- Nature-identical polysaccharides are understood to mean polymers which either do not occur in nature or only in a mixture with other compounds, which can also be other polymers.
- Such nature-identical polymers can be produced by processes which fall under the broadest definition of the term biotechnological and genetic engineering processes. On the one hand, this includes biotechnical processes or processes, as will be defined below, but also those that lead to corresponding connections through the use and modification of, for example, bacteria, fungi or algae.
- the term also includes, for example, polysaccharides which can be obtained by applying bio- or genetic engineering processes to higher plants, so that separation from the plant can take place. Such plants include, in particular, the potato, corn, cereals, cassava, rice and peas. However, other plants which produce polysaccharides can also be classified in this category from the aspect of the invention.
- Linear, water-insoluble polysaccharides which are used in a biotechnical, in particular a biocatalyzed 9 tables can also be produced using a biotransformer or a fermentative process.
- Linear polysaccharides produced by biocatalysis in the context of this invention means that the linear polysaccharide by catalytic reaction of monomeric building blocks such as oligomeric saccharides, e.g. of mono- and / or disaccharides is produced by using a so-called biocatalyst, usually an enzyme, under suitable conditions for use in the reaction.
- biocatalyst usually an enzyme
- Linear polysaccharides from fermentations are, in the parlance of the invention, linear polysaccharides which are obtained by fermentative processes using organisms found in nature, such as, for example, fungi, algae or bacteria, or using organisms not occurring in nature, but with the aid of genetic engineering Methods of general definition modified natural organisms, such as fungi, algae or bacteria can be obtained.
- linear polysaccharides can also be obtained by treating nonlinear polysaccharides containing branches with one or more enzymes such that the branches are cleaved from the backbone of the polysaccharide so that after it Separation linear polysaccharides are present.
- enzymes are, for example, amylases, iso-amylases, pullulanases or also gluconohydrolases. 10
- sparingly soluble to practically insoluble compounds in particular very sparingly soluble to practically insoluble compounds, are preferred.
- the preferred poly- (1,4- ⁇ -D-glucan) can be produced in various ways. A very advantageous method is described in WO 95/31553. The revelation of Scripture is explicitly mentioned here 11 related.
- the poly- (1,4- ⁇ -D-glucan) is produced by means of a biocatalytic (biotransformatory) process using amylosucrase.
- the poly- (1,4- ⁇ -D-glucan) can be produced using polysaccharide synthases, starch synthases, glycol transferases, 1,4- ⁇ -D-glucan transferases, glycogen synthases or phosphorylases by means of a biocatalytic process.
- the spherical microparticles are produced by dissolving the water-insoluble, linear polysaccharide, in particular the poly- (1,4-D-glucan), in a solvent, particularly preferably in DMSO, introducing the solution into a precipitant, preferably water, cooling the resulting mixture to preferably 10 ° C to -10 ° C and separating the microparticles formed.
- a precipitant preferably water
- suitable additives are, for example, surfactants such as sodium dodecyl sulfate or N-methylglucanoamide, sugar, e.g. Fructose, sucrose, glucose.
- the molecular weights M w of the linear polysaccharides used according to the invention can vary within a wide range from 10 3 g / mol to 10 7 g / mol.
- the molecular weight M w describes the weight average of the molecular weight and is determined using gel per 12 meation chromatography compared to a calibration with pullulin standards.
- the particles can have mean diameters (number average) such as 1 nm to 100 ⁇ m, preferably 100 nm to 10 ⁇ m, particularly preferably 1 ⁇ m to 5 ⁇ m.
- the distribution of the diameters is characterized by a high level of uniformity.
- microparticles made of poly (1,4-D-glucan) are distinguished by a specific surface area of 1 m 2 / g to 100 m 2 / g, particularly preferably 3 m 2 / g to 10 m 2 / g.
- n-Hexane e.g. n-Hexane, dichloromethane, tetrahydrofuran, 1,4-dioxane, ethanol, acetone, acetonitrile, methanol, n-heptane and water are used.
- eluent e.g. n-Hexane, dichloromethane, tetrahydrofuran, 1,4-dioxane, ethanol, acetone, acetonitrile, methanol, n-heptane and water are used.
- microparticles of linear polysaccharides are slurried, whirled up by means of an Ultraturrax and degassed in an ultrasonic bath.
- a solvent for example n-heptane
- the supension is filled into a column and packed evenly and densely by constant tapping on the column, constant shaking in combination with brief treatment in an ultrasonic bath, so that low-volume packs are created.
- the separations are carried out in a state-of-the-art chromatography system for HPLC.
- the sample concentration is 2.0 to 0.025 mg / l solvent, particularly preferably 0.25 to 0.05 mg / l solvent.
- the elution rate is 2.0 to 0.25 ml / min, preferably 1.0 to 0.4 ml / min, particularly preferably 0.5 ml / min.
- This information may vary depending on the solvent used.
- the prints used are strongly dependent on the polarity of the solvent. 13 pending. They are generally in a range between 30 bar and 200 bar. For example, the following pressures were measured: 138 to 159 bar for acetonitrile, about 100 bar for ethyl acetate, about 62 bar for t-butyl methyl ether and 54 to 70 bar for n-heptane.
- An internal standard for example 1,3,5-tri-tert-butylbenzene, can be used.
- Fig. 1 Scanning electron microscope image (see Example 4) of the spherical microparticles used in 5000x magnification.
- Fig. 2 Scanning electron microscope image (see Example 4) of the spherical microparticles used in 10000x magnification.
- Fig. 3 Scanning electron microscope image (see Example 4) of the spherical microparticles used in 15000x magnification.
- Fig. 4 Scanning electron microscope image (see Example 4) of the spherical microparticles used in 20000x magnification.
- 5 Agarose gel (detection with ethidium bromide 0.5 pg / ml at 256 nm) according to
- Example 12 see legend. 6: agarose gel (detection with ethidium bromide 0.5 pg / ml at 256 nm) according to
- a) 400 g of poly (1,4- ⁇ -D-glucan) are dissolved in 2 l of dimethyl sulfoxide (DMSO, p.a. from Riedel-de-Haen) at 60 ° C within 1.5 hours. Then it is stirred for one hour at room temperature. The solution is added in 20 l of double-distilled water with stirring through a dropping funnel over a period of 2 h. The mixture is stored at 4 ° C. for 44 h. A fine suspension is formed. The particles are separated by first decanting the supernatant. The sediment is slurried and centrifuged in small portions (RC5C ultracentrifuge: 5 minutes each at 5000 revolutions per minute).
- DMSO dimethyl sulfoxide
- the measurements of the specific surface are made with a Sorptomatic 1990 (from Fisons Instruments). The ' default method sorptomatic ' method is used for evaluation. For the examination, the samples are dried at 80 ° C. in a vacuum (membrane pump from Vacuubrand GmbH & Co., CVC 2) overnight. The potato starch and the poly- (1,4- ⁇ -D-glucan) obtained directly from the biotransformation are ground beforehand so that the mass of the 18th
- Particle is in the range of less than 200 microns.
- a commercially available mill is used for this (Waring®).
- the procedure is as follows: 100 mg of the particles from Example 3 are overlaid with 3 ml of the solvent in a crimp-top vial. The observation time is 24 hours. The particles are examined every hour for changes. For this purpose, the reaction vessel is swiveled.
- Example 3a 5 g of the particles from Example 3a are slurried in about 60 ml of heptane.
- the suspension is briefly whirled up using an Ultraturrax (Ika) and then degassed in an ultrasonic bath (Sonorex Super RK510H).
- the suspension is then filled under maximum flow into a column measuring 125 mm in length and 4 mm in diameter (Hibar® finished column from Merck AG). Constant tapping on the column, or constant shaking of the column in combination with short-term, approximately one-minute treatment in the ultrasonic bath ensures a tight and even packing of the separating material, so that packs with low dead volume result.
- the separations are carried out in a Lichograph® chromatography system from Merck.
- the individual components are: a gradient pump L 6200 A, a UV detector L-400 (measurement at 254 nm), a chromato-integrator D-2500 and a separation column Hibar® RT-125-4.
- the sample concentration is ideally 0.05 to 0.1 mg / ml solvent. 1,3,5-tritert.-butylbenzene (from Fluka) can be used as the internal standard.
- the chromatography column is prepared with n-heptane (Aldrich for HPLC). The plant is operated with n-heptane. The elution rate is 0.5 ml / min. The pressure is 54 bar. The substances to be separated are: indole and 2-methylindole. 21
- Example 10 The test is carried out analogously to Example 10. In this example the pressure is around 70 bar. The concentration of the samples is 0.25 mg / ml solvent. 22
- Disposable centrifuge filters (Schleicher & Schull, eg Centrix, catalog number 467012 (April 1996): "Filter 1" in FIGS. 5 and 6) are used with 580 mg of the microparticles produced as in Example 3 as filter material or adsorbent with 3 ml of a buffer 1 (see below) Equilibrated solution (possibly centrifuge (2000 rpm)) Then 2 ml of an aqueous DNA plasmid solution (plasmid used: pBluescript II SK) with a concentration of 50 ⁇ g / ml are added to the filter (centrifuge if necessary) (5min at 2000 rpm)) There is a reference run with (“Filter 2" in Fig. 5 and 6) Qiagen® Midi drapep (Hilden, Germany) and another reference run with Qiagen® Midi ebookp - cartridges without Qiagen® filter medium, which were equipped with the separating material.
- Each 5 ⁇ l eluate is provided with about 1/10 of the concentration with staining reagent (marker) and applied to an agarose gel plate (60% sucrose, 20 mM EDTA, 0.025% bromophenol blue) with subsequent gel electrophoresis (company Biorad, Power Supply, model 100 / 200).
- staining reagent labeled with staining reagent
- an agarose gel plate (60% sucrose, 20 mM EDTA, 0.025% bromophenol blue) with subsequent gel electrophoresis (company Biorad, Power Supply, model 100 / 200).
- a marker MG 5,000
- the DNA plasmid solution used are applied as a reference.
- Fig. 5 shows that on 23 separating material according to the invention (here filter means) the sample DNA was retained.
- buffer 2 a second buffer (buffer 2) are added to the column (filter) for elution and processed quickly by centrifugation (5 min at 2000 rpm).
- the eluates (references as mentioned above) are applied to an agarose gel plate (60% sucrose, 20 mM EDTA, 0.025% bromophenol blue) and then gel electrophoresis (company Biorad, Power Supply, model 100/200) is carried out (see FIG. 6).
- a marker MW 5,000
- the DNA plasmid solution lane 7
- FIG. 6 shows that when the separating material according to the invention is used, the plasmid DNA used is again eluted from the column.
- the comparison with commercially available filter media shows the quality of the filter process, which has at least the same quality.
- Buffer 1 750 mM NaCl
- Lane t marker (Boehringer Mannheim DNA Molecular Weight Marker X) lane 2 filter 2 without separating material (blind reference) lane 3 filter 2 filled with separating material according to the invention lane 4 filter 1: Qiagen® cartridge with separating material according to the invention lane 5 filter 1: Qiagen® Midi drapep (Hilden , Germany) Reference lane 6 Filter 2 with separation material lane 7 pure DNA plasmid solution (commercially available plasmid pBluescript II SK)
- Lane marker (Boehringer Mannheim DNA Molecular Weight Marker X) lane 2 filter 2 without separating material (blind reference)
- Track 3 filter 2 filled with separating material according to the invention.
- Track 4 filter 1 Qiagen® cartridge with separating material according to the invention.
- Track 5 filter 1 Qiagen® Midi drapep (Hilden, Germany).
- Track 7 pure DNA plasmid solution (commercial plasmid pBluescript II SK)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000529314A JP2002501811A (ja) | 1998-01-29 | 1999-01-26 | 多糖類を使用する物質混合物の分離 |
| EP99907417A EP1071499A1 (fr) | 1998-01-29 | 1999-01-26 | Procede de separation de melanges de substances au moyen de polysaccharides |
| AU27189/99A AU2718999A (en) | 1998-01-29 | 1999-01-26 | Separation of substance mixtures using polysaccharides |
| CA002319386A CA2319386A1 (fr) | 1998-01-29 | 1999-01-26 | Procede de separation de melanges de substances au moyen de polysaccharides |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803415.6 | 1998-01-29 | ||
| DE19803415A DE19803415A1 (de) | 1998-01-29 | 1998-01-29 | Trennung von Stoffgemischen unter Einsatz von Polysacchariden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999038594A1 true WO1999038594A1 (fr) | 1999-08-05 |
Family
ID=7856014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP1999/000473 WO1999038594A1 (fr) | 1998-01-29 | 1999-01-26 | Procede de separation de melanges de substances au moyen de polysaccharides |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1071499A1 (fr) |
| JP (1) | JP2002501811A (fr) |
| CN (1) | CN1289263A (fr) |
| AU (1) | AU2718999A (fr) |
| CA (1) | CA2319386A1 (fr) |
| DE (1) | DE19803415A1 (fr) |
| WO (1) | WO1999038594A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19860371A1 (de) | 1998-12-28 | 2000-06-29 | Aventis Res & Tech Gmbh & Co | Kosmetische oder medizinische Zubereitung für die topische Anwendung |
| JPWO2006082968A1 (ja) * | 2005-02-07 | 2008-06-26 | 江崎グリコ株式会社 | α−1,4−グルカンを含有する吸着剤およびその製造方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377046A1 (fr) * | 1988-04-05 | 1990-07-11 | Kanebo Ltd. | Particules fines de cellulose poreuse echangeuse d'ions, procede pour leur production, et porteur d'affinite |
| WO1995005879A1 (fr) * | 1993-08-27 | 1995-03-02 | The Dow Chemical Company | Procede pour la separation d'enantiomeres |
| WO1997038018A1 (fr) * | 1996-04-11 | 1997-10-16 | Amersham Pharmacia Biotech Ab | Procede de production d'un gel polysaccharidique reticule poreux et son utilisation comme support pour filtration sur gel et en chromatographie |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0321597B1 (fr) * | 1986-09-09 | 1992-11-11 | Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. | Adsorbant sélectif pour lier les lipoprotéines de faible densité |
| JPS6419024A (en) * | 1987-07-15 | 1989-01-23 | Tosoh Corp | Separation of immunoglobulin g subclass |
-
1998
- 1998-01-29 DE DE19803415A patent/DE19803415A1/de not_active Withdrawn
-
1999
- 1999-01-26 CN CN99802491A patent/CN1289263A/zh active Pending
- 1999-01-26 CA CA002319386A patent/CA2319386A1/fr not_active Abandoned
- 1999-01-26 AU AU27189/99A patent/AU2718999A/en not_active Abandoned
- 1999-01-26 EP EP99907417A patent/EP1071499A1/fr not_active Withdrawn
- 1999-01-26 JP JP2000529314A patent/JP2002501811A/ja active Pending
- 1999-01-26 WO PCT/EP1999/000473 patent/WO1999038594A1/fr not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377046A1 (fr) * | 1988-04-05 | 1990-07-11 | Kanebo Ltd. | Particules fines de cellulose poreuse echangeuse d'ions, procede pour leur production, et porteur d'affinite |
| WO1995005879A1 (fr) * | 1993-08-27 | 1995-03-02 | The Dow Chemical Company | Procede pour la separation d'enantiomeres |
| WO1997038018A1 (fr) * | 1996-04-11 | 1997-10-16 | Amersham Pharmacia Biotech Ab | Procede de production d'un gel polysaccharidique reticule poreux et son utilisation comme support pour filtration sur gel et en chromatographie |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2718999A (en) | 1999-08-16 |
| EP1071499A1 (fr) | 2001-01-31 |
| JP2002501811A (ja) | 2002-01-22 |
| CN1289263A (zh) | 2001-03-28 |
| DE19803415A1 (de) | 1999-08-05 |
| CA2319386A1 (fr) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hosseini et al. | Synthesis of nanohydrogels based on tragacanth gum biopolymer and investigation of swelling and drug delivery | |
| EP1012204B1 (fr) | Micro particules spheriques contenant des polysaccharides lineaires | |
| Günter et al. | Calcium pectinate gel beads obtained from callus cultures pectins as promising systems for colon-targeted drug delivery | |
| Gan et al. | Chitosan nanoparticle as protein delivery carrier—systematic examination of fabrication conditions for efficient loading and release | |
| DE60015137T2 (de) | Mit material gefülllte geschäumte substanz | |
| Nazlı et al. | Loading of cancer drug resveratrol to pH-Sensitive, smart, alginate-chitosan hydrogels and investigation of controlled release kinetics | |
| DE2365265C2 (de) | Molekularsieb und dessen Herstellung | |
| DE10036907B4 (de) | Verfahren zur Herstellung einer Beschichtung auf einem mit Gold bedampften Glassubstrat, Beschichtung hergestellt nach diesem Verfahren und deren Verwendung | |
| Falahati et al. | Preparation of Balangu (Lallemantia royleana) seed mucilage aerogels loaded with paracetamol: Evaluation of drug loading via response surface methodology | |
| DE69834558T2 (de) | Trennmittel für optische isomere und verfahren zu ihrer herstellung | |
| DE69822934T2 (de) | Chirale Trennung von pharmazeutischen Verbindungen mit geladenen Cyclodextrinen durch Kapillarelektrophorese | |
| EP0154246A1 (fr) | Supports de phase pour la chromatographie de partage de macromolécules, procédé pour leur préparation et leur application | |
| Li et al. | Melatonin loaded with bacterial cellulose nanofiber by Pickering-emulsion solvent evaporation for enhanced dissolution and bioavailability | |
| Gümüşderelioğlu et al. | Adsorption of concanavalin A on the well-characterized macroporous chitosan and chitin membranes | |
| Mocanu et al. | Synthesis of new associative gel microspheres from carboxymethyl pullulan and their interactions with lysozyme | |
| DE69226578T2 (de) | Production eines Zellulosederivates | |
| Vieira et al. | Stationary phase based on cellulose dodecanoate physically immobilized on silica particles for high-performance liquid chromatography | |
| WO2000012590A1 (fr) | Procede de preparation de microparticules spheriques, consistant en partie ou en totalite en au moins un polyglucane contenant des ramifications non solubles dans l'eau, et microparticules obtenues a l'aide dudit procede | |
| EP1071499A1 (fr) | Procede de separation de melanges de substances au moyen de polysaccharides | |
| DE60222243T2 (de) | Trennmittel für optisches isomer | |
| KR930010463B1 (ko) | 폴리아미노산 구형 입자들의 제조방법 | |
| US4937081A (en) | Process for producing porous, spherical particles | |
| EP1117730A1 (fr) | Procede de preparation de petites particules spheriques contenant au moins un polysaccharide lineaire soluble dans l'eau | |
| DE19902917A1 (de) | Wasserunlösliche lineare Polysaccharide zur Filtration | |
| WO1999052558A1 (fr) | Comprime a liberation controlee produit a partir de polysaccharides lineaires insolubles dans l'eau |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 99802491.0 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN CZ HU JP KR NZ PL US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1999907417 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2319386 Country of ref document: CA Ref document number: 2319386 Country of ref document: CA Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09600763 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1999907417 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1999907417 Country of ref document: EP |